PTI-202 / Cassava - LARVOL DELTA

"retweet survey @PTIofficial @ImranKhanPTI @AsadQaiserPTI @dolly_qureshi @shiblifaraz @FaisalJavedKhan @MuradSaeedPTI @thefixxinco @Ali_MuhammadPTI @RajaBasharatLAW @Multan_PTI2020 @PTI_TIGERS4 @PTIadil1 @Karachi__Wali @WasifHasan19 @RBH_PTI @AmmaraZahid4 @NailaUsmani1 @APPNA" (@sehbaia)

"Retweet @p4pakipower @PTIKPOfficial @PTI_TIGERS4 @pti @FatimaPTI_IK @Multan_PTI2020 @Rabbia112233 @Karachi__Wali @PTIadil1 @PTIadil1 @Waqasalinew @naziarubbani @ptifamily @KhalidaMehmood6 @PTIOfficialRWP @AmmaraZahid4 @PTIOfficialSKT @IlyasKhalil20 @pti_saeen @PTIVideos" (@sehbaia)

"retweet @ImranKhanPTI @SMQureshiPTI @Ali_MuhammadPTI @AliHZaidiPTI @AndleebAbbas @PTIOkaara @ZiaBangashPTI @ptilawyer1 @Multan_PTI2020 @PTILahorePunjab @AliAminKhanPTI @OfficialDGISPR @dgprPaknavy @ArifAlvi @" (@sehbaia)

"Thanks @shona_brierton for all your help with #kisspeptin2022 and #icn2022" (@WaljitD)

"Tamperelaisen Anssi Räntilän kokeilut uuden #kaurapasta'n kehityksessä eivät menneet aivan putkeen. 😅 Luomisen tuskaa Suomalainen #Menestysresepti 2021 -kisassa. Hyvä #pasta siitä tulee! 🤟 » Lue lisää: https://t.co/h1vsfWCU49 #innovaatio #Maikkari #SMR2021 #ruoka #kauppa" (@sryhma)

Pain Therapeutics reports Pfizer elects to continue development of Remoxy (Pain Therapeutics Press Release) - "Pain Therapeutics, Inc. (Nasdaq:PTIE) today reported Pfizer Inc. (NYSE:PFE) has informed us that, having achieved technical milestones related to manufacturing, they will continue the development program for REMOXY® (oxycodone) Extended-Release Capsules CII....The complete response submission is not expected to occur prior to mid-2015....Pfizer has returned to us all rights with respect to abuse-resistant formulations of hydrocodone, hydromorphone and oxymorphone....We are now free to develop and commercialize these assets on our own or with a licensee of our choice, and may do so without notice or approval from Pfizer."

Anticipated FDA event • Pipeline update • Pain